InvestSMART

BlinkLab Limited (ASX: BB1) - Announcements

Current share price for BB1 : $0.630 0.015 (2.33%)+

ASX company news and announcements for BlinkLab Limited (BB1) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All BlinkLab Limited (BB1) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than BlinkLab Limited (BB1), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for BlinkLab Limited (BB1)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$111 Application for quotation of securities - BB1 13 Jul 2026 2:35PM $0.605 $0.630 risen by 4.13%
$111 Notification regarding unquoted securities - BB1 1 Jul 2026 4:44PM $0.660 $0.630 fallen by 4.55%
$111 European ADHD Study Update 26 Jun 2026 9:22AM $0.600 $0.630 risen by 5%
$111 Results of General Meeting 25 Jun 2026 4:53PM $0.600 $0.630 risen by 5%
$111 BB1 Granted Foundational U.S. Patent 18 Jun 2026 9:20AM $0.640 $0.630 fallen by 1.56%
$111 BB1 Partners with ESPOCH on Large-Scale Multicenter Program 16 Jun 2026 9:11AM $0.640 $0.630 fallen by 1.56%
$111 Letter to Shareholders & Proxy Form 22 May 2026 11:22AM $0.710 $0.630 fallen by 11.27%
$111 Notice of General Meeting & Proxy Form 22 May 2026 11:20AM $0.710 $0.630 fallen by 11.27%
$111 Therapy Evaluation for Neurodevelopmental Conditions 19 May 2026 9:46AM $0.665 $0.630 fallen by 5.26%
$111 BB1 to present at Stocks in the Vines Investor Access Day 14 May 2026 9:33AM $0.660 $0.630 fallen by 4.55%
$111 Quarterly Activities/Appendix 4C Cash Flow Report 30 Apr 2026 8:39AM $0.665 $0.630 fallen by 5.26%
$111 Section 708A Notice 23 Apr 2026 9:46AM $0.710 $0.630 fallen by 11.27%
$111 Application for quotation of securities - BB1 23 Apr 2026 9:41AM $0.710 $0.630 fallen by 11.27%
$111 BlinkLab Invited to Present at Ignite Investment Summits 17 Apr 2026 9:23AM $0.725 $0.630 fallen by 13.10%
$111 Update - Proposed issue of securities - BB1 16 Apr 2026 5:44PM $0.725 $0.630 fallen by 13.10%
$111 Proposed issue of securities - BB1 16 Apr 2026 9:28AM $0.785 $0.630 fallen by 19.75%
$111 BlinkLab Secures A$17.5M to Launch Autism Diagnostic Aid 16 Apr 2026 9:27AM $0.785 $0.630 fallen by 19.75%
$111 Trading Halt 14 Apr 2026 9:00AM $0.785 $0.630 fallen by 19.75%
$111 Application for quotation of securities - BB1 7 Apr 2026 12:22PM $0.795 $0.630 fallen by 20.75%
$111 Notice of Release of Escrowed Securities 26 Mar 2026 10:51AM $0.785 $0.630 fallen by 19.75%
$111 Validation Program Commences-FDA 510(k) - First Participant 24 Mar 2026 9:35AM $0.775 $0.630 fallen by 18.71%
$111 Morocco's Nationwide Government-Funded Autism Screening 23 Mar 2026 9:48AM $0.830 $0.630 fallen by 24.10%
$111 Trading Halt 19 Mar 2026 9:38AM $0.830 $0.630 fallen by 24.10%
$111 Clinical Trial Network for Pivotal FDA Study Complete 16 Mar 2026 9:44AM $0.860 $0.630 fallen by 26.74%
$111 BlinkLab Forms Partnership with SHANK2 Autism Foundation 13 Mar 2026 9:21AM $0.845 $0.630 fallen by 25.44%

26 - 50 of 195 results

Page 2 of 8

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.